Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Turiello

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
European Journal of Immunology|June 20, 2025
NKG7 is a Stable Marker of Cytotoxicity Across Immune Contexts and Within the Tumor MicroenvironmentRoberta Turiello, Susanna S Ng, Elisabeth Tan, et al.
Journal of Translational Medicine|March 13, 2020
Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patientsMariaelena Capone, Federica Fratangelo, Diana Giannarelli, et al.
Nature Communications|May 28, 2024
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trialFrank A Giordano, Julian P Layer, Sonia Leonardelli, et al.
Journal for Immunotherapy of Cancer|December 28, 2020
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapyRoberta Turiello, Mariaelena Capone, Diana Giannarelli, et al.
Journal for Immunotherapy of Cancer|April 7, 2023
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanomaLuiza Martins Nascentes Melo, Dayana Herrera-Rios, Daniel Hinze, et al.
Nature Communications|April 8, 2026
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trialFrank A Giordano, Julian P Layer, Roberta Turiello, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
European Journal of Immunology|June 20, 2025
NKG7 is a Stable Marker of Cytotoxicity Across Immune Contexts and Within the Tumor MicroenvironmentRoberta Turiello, Susanna S Ng, Elisabeth Tan, et al.
Journal of Translational Medicine|March 13, 2020
Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patientsMariaelena Capone, Federica Fratangelo, Diana Giannarelli, et al.
Nature Communications|May 28, 2024
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trialFrank A Giordano, Julian P Layer, Sonia Leonardelli, et al.
Journal for Immunotherapy of Cancer|December 28, 2020
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapyRoberta Turiello, Mariaelena Capone, Diana Giannarelli, et al.
Journal for Immunotherapy of Cancer|April 7, 2023
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanomaLuiza Martins Nascentes Melo, Dayana Herrera-Rios, Daniel Hinze, et al.
Nature Communications|April 8, 2026
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trialFrank A Giordano, Julian P Layer, Roberta Turiello, et al.
Pageof 2